We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Transfusion Management System Assures Patient Safety

By Labmedica staff writers
Posted on 29 Jul 2008
A point-of-care (POC) transfusion safety management system assists nurses, phlebotomists, and laboratory personnel in assuring that blood samples are drawn from correct patients and administered to suitable patients. More...


The new POC transfusion safety-management system is composed of computers, a software application, wireless handheld barcode scanners, and wireless printers. In addition to helping laboratory personnel in the accurate matching of blood samples with correct blood or blood products, it enables immediate documentation of any adverse reaction data.

A product of IntelliDOT Corp. (San Diego, CA, USA), the management system is called the IntelliDOT blood product administration (IntelliDOT BPA). The company announced that the U.S. Food and Drug Administration (FDA; Rockville, MD, USA) granted 510(k) clearance for the IntelliDOT BPA for commercial sale.

"The FDA approval for IntelliDOT blood product administration advances our corporate mission to provide innovative and easy-to-adopt, point-of-care solutions to enhance patient safety, improve nurse efficiency, and help hospitals reduce risk and liability,” said Thomas G. Klopack, president and CEO of IntelliDOT. "With this latest addition, IntelliDOT extends its ability to support improved quality of care across the full spectrum of patient needs.”

IntelliDOT BPA is an integrated module of the IntelliDOT CAREt system, the manager that connects caregivers with the information systems they need at the point-of-care. The other currently available modules in the CAREt system include: IntelliDOT bedside medication administration, IntelliDOT phlebotomy specimen collection, IntelliDOT mother-baby breast milk matching, and IntelliDOT vital signs collection.

IntelliDOT is a provider of wireless, handheld, barcode point-of- care (BPOC) solutions that connect to any healthcare information system to improve patient safety and nurse workflow. When using the IntelliDOT system, nurses can easily manage all tasks associated with medication-administration safety checks and related documentation.


Related Links:
U.S. Food and Drug Administration
IntelliDOT

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Urine Analyzer
respons® UDS100
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.